{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T21:02:10Z","timestamp":1784581330395,"version":"3.55.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jad.2026.122156","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T22:07:22Z","timestamp":1782079642000},"page":"122156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Investigating the effects of antidepressants on measures of insulin resistance in major depressive disorder: A systematic review"],"prefix":"10.1016","volume":"412","author":[{"given":"Sabrina","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gia Han","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Jing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernan F.","family":"Guillen-Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Dri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Teopiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-2523","authenticated-orcid":false,"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.122156_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13030384","article-title":"Neurotransmitters in type 2 diabetes and the control of systemic and central energy balance","volume":"13","author":"Al-Sayyar","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.jad.2026.122156_bb0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000100369","article-title":"Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus","volume":"54","author":"Amsterdam","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2026.122156_bb0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2337\/diacare.27.1.129","article-title":"Depressive symptoms and risk of type 2 diabetes in women","volume":"27","author":"Arroyo","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jad.2026.122156_bb0020","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/ijp.ijp_907_24","article-title":"Efficacy and safety of dextromethorphan-bupropion combination (AXS-05) in the treatment of depression: a systematic review and network meta-analysis","volume":"57","author":"Ashwin","year":"2025","journal-title":"Indian J. Pharm."},{"key":"10.1016\/j.jad.2026.122156_bb0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.peptides.2015.07.008","article-title":"Altered serotonin (5-HT) 1D and 2A receptor expression may contribute to defective insulin and glucagon secretion in human type 2 diabetes","volume":"71","author":"Bennet","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.jad.2026.122156_bb0030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/02698811241309612","article-title":"The efficacy of vortioxetine in the acute treatment of major depressive disorder: a systematic review and meta-analysis","volume":"39","author":"Berardelli","year":"2025","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122156_bb0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4306\/pi.2013.10.2.148","article-title":"Relationship between SSRIs and metabolic syndrome abnormalities in patients with generalized anxiety disorder: a prospective study","volume":"10","author":"Beyazy\u00fcz","year":"2013","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.jad.2026.122156_bb0040","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1126\/science.130678","article-title":"Hyperphagia and obesity following serotonin depletion by intraventricular p-chlorophenylalanine","volume":"192","author":"Breisch","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.jad.2026.122156_bb0045","article-title":"Imipramine accelerates nonalcoholic fatty liver disease, renal impairment, diabetic retinopathy, insulin resistance, and urinary chromium loss in obese mice","volume":"8","author":"Chang","year":"2021","journal-title":"Vet. Sci."},{"key":"10.1016\/j.jad.2026.122156_bb0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jad.2013.04.008","article-title":"The change of insulin levels after six weeks antidepressant use in drug-na\u00efve major depressive patients","volume":"150","author":"Chang","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122156_bb0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jad.2007.01.023","article-title":"Comparisons of glucose\u2013insulin homeostasis following maprotiline and fluoxetine treatment in depressed males","volume":"103","author":"Chen","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122156_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111848","article-title":"Fluoxetine ameliorates high-fat diet-induced metabolic abnormalities partially via reduced adipose triglyceride lipase-mediated adipocyte lipolysis","volume":"141","author":"Chiu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jad.2026.122156_bb0065","first-page":"1","article-title":"Insulin resistance and poorer treatment outcomes in depression: evidence from UK biobank primary care data","author":"Fanelli","year":"2025","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122156_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104758","article-title":"Insulin resistance in depression: a large meta-analysis of metabolic parameters and variation","volume":"139","author":"Fernandes","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2026.122156_bb5000","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ajp.2013.03.007","article-title":"Diabetes with comorbid depression: role of SSRI in better glycemic control","volume":"6","author":"Gehlawat","year":"2013","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.jad.2026.122156_bb0075","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/01.jcp.0000132441.27854.0d","article-title":"Comparing the effects of 8-week treatment with fluoxetine and imipramine on fasting blood glucose of patients with major depressive disorder","volume":"24","author":"Ghaeli","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122156_bb0080","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/oby.22969","article-title":"Antidepressant medications and weight change: a narrative review","volume":"28","author":"Gill","year":"2020","journal-title":"Obesity"},{"key":"10.1016\/j.jad.2026.122156_bb0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jad.2024.12.090","article-title":"Metabolic factors modulate effort-based decision-making in major depressive disorder","volume":"373","author":"Gill","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122156_bb0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.arcmed.2004.12.018","article-title":"Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients","volume":"36","author":"G\u00fclseren","year":"2005","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.jad.2026.122156_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2019.01.016","article-title":"Brain insulin resistance: a treatment target for cognitive impairment and anhedonia in depression","volume":"315","author":"Hamer","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jad.2026.122156_bb0100","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/1871530315666150623092031","article-title":"Weight gain and metabolic changes during treatment with antipsychotics and antidepressants","volume":"15","author":"Himmerich","year":"2015","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.jad.2026.122156_bb0105","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1074\/jbc.M112.408641","article-title":"Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic \u03b2 cells","volume":"288","author":"Isaac","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jad.2026.122156_bb0110","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2337\/dc12-1442","article-title":"A systematic review and Meta-analysis of the association between depression and insulin resistance","volume":"36","author":"Kan","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jad.2026.122156_bb0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/ijcp.12112","article-title":"Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus","volume":"67","author":"Karaiskos","year":"2013","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.jad.2026.122156_bb0120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/09513590500216800","article-title":"Impact of the selective serotonin reuptake inhibitor citalopram on insulin sensitivity, leptin and basal cortisol secretion in depressed and non-depressed euglycemic women of reproductive age","volume":"21","author":"Kauffman","year":"2005","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.jad.2026.122156_bb0125","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2026.122156_bb0130","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/wps.20241","article-title":"Antidepressants versus placebo in major depression: an overview","volume":"14","author":"Khan","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2026.122156_bb5005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17712\/1658-3183.1831","article-title":"Treatment of depression in type 2 diabetes with Fluoxetine or Citalopram?","volume":"16","author":"Khazaie","year":"2011","journal-title":"Neurosciences (Riyadh)"},{"key":"10.1016\/j.jad.2026.122156_bb0135","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2337\/db14-0568","article-title":"Insulin action in brain regulates systemic metabolism and brain function","volume":"63","author":"Kleinridders","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jad.2026.122156_bb0140","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12888-015-0567-x","article-title":"Association between suicidal behaviour and impaired glucose metabolism in depressive disorders","volume":"15","author":"Koponen","year":"2015","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2026.122156_bb0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/YCO.0000000000000905","article-title":"Consolidating evidence on the role of insulin resistance in major depressive disorder","volume":"37","author":"Krupa","year":"2024","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122156_bb0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/00325481.2025.2478812","article-title":"Treating obesity in patients with depression: a narrative review and treatment recommendation","volume":"137","author":"Kushner","year":"2025","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.jad.2026.122156_bb0155","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4088\/JCP.v67n0313","article-title":"Effect of mirtazapine treatment on body composition and metabolism","volume":"67","author":"Laimer","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122156_bb0160","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pbb.2010.09.003","article-title":"Brain serotonin system in the coordination of food intake and body weight","volume":"97","author":"Lam","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jad.2026.122156_bb5020","article-title":"Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine","author":"Lederbogen","year":"2006","journal-title":"Psychiatrist"},{"key":"10.1016\/j.jad.2026.122156_bb0165","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00006842-199705000-00007","article-title":"Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial","volume":"59","author":"Lustman","year":"1997","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jad.2026.122156_bb0170","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2337\/diacare.23.5.618","article-title":"Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial","volume":"23","author":"Lustman","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jad.2026.122156_bb0175","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2337\/dc06-1769","article-title":"Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion","volume":"30","author":"Lustman","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jad.2026.122156_bb0180","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2337\/diabetes.50.2.376","article-title":"Central infusion of histamine reduces fat accumulation and upregulates UCP family in leptin-resistant obese mice","volume":"50","author":"Masaki","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jad.2026.122156_bb0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.metabol.2015.10.019","article-title":"Metabolic health and weight: understanding metabolically unhealthy normal weight or metabolically healthy obese patients","volume":"65","author":"Mathew","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jad.2026.122156_bb0190","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.25com16021","article-title":"Practitioners providing care for persons with severe mental disorders should routinely screen for metabolic dysfunction-associated steatotic liver disease","volume":"86","author":"McIntyre","year":"2025","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122156_bb0195","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1517\/14740338.5.4.523","article-title":"The effect of antidepressants on lipid homeostasis: a cardiac safety concern?","volume":"5","author":"McIntyre","year":"2006","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jad.2026.122156_bb0200","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122156_bb0205","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2026.122156_bb0210","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1176\/appi.ajp.20230922","article-title":"Psychotropic drug\u2013related weight gain and its treatment","volume":"181","author":"McIntyre","year":"2024","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122156_bb0215","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.2337\/db13-1371","article-title":"Control of insulin secretion by cholinergic signaling in the human pancreatic islet","volume":"63","author":"Molina","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jad.2026.122156_bb0220","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/01.jcp.0000095341.32154.8f","article-title":"African women with depression: the effect of imipramine and fluoxetine on body mass index and leptin secretion","volume":"23","author":"Moosa","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122156_bb0225","doi-asserted-by":"crossref","first-page":"183","DOI":"10.26502\/acbr.50170450","article-title":"Impact of antidepressants on weight gain: underlying mechanisms and mitigation strategies","volume":"9","author":"Mouawad","year":"2025","journal-title":"Arch. Clin. Biomed. Res."},{"key":"10.1016\/j.jad.2026.122156_bb0230","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.122156_bb0235","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.euroneuro.2008.08.009","article-title":"Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD","volume":"19","author":"Papakostas","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.122156_bb0240","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2337\/dc14-1599","article-title":"Cognitive behavioral therapy versus sertraline in patients with depression and poorly controlled diabetes: the diabetes and depression (DAD) study: a randomized controlled multicenter trial","volume":"38","author":"Petrak","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jad.2026.122156_bb0245","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(25)01293-0","article-title":"The effects of antidepressants on cardiometabolic and other physiological parameters: a systematic review and network meta-analysis","volume":"406","author":"Pillinger","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2026.122156_bb0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuropharm.2015.07.002","article-title":"The histaminergic system as a target for the prevention of obesity and metabolic syndrome","volume":"106","author":"Provensi","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2026.122156_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.728810","article-title":"Update on the relationship between depression and neuroendocrine metabolism","volume":"15","author":"Qiu","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jad.2026.122156_bb0260","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pcd.2018.09.003","article-title":"Impact of sertraline on weight, waist circumference and glycemic control: a prospective clinical trial on depressive diabetic type 2 patients","volume":"13","author":"Rachdi","year":"2019","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.jad.2026.122156_bb0265","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/02698811221132473","article-title":"Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder","volume":"37","author":"Rashidian","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122156_bb0270","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/oby.2010.176","article-title":"Association of prescription H1 antihistamine use with obesity: results from the National Health and nutrition examination survey","volume":"18","author":"Ratliff","year":"2010","journal-title":"Obesity"},{"key":"10.1016\/j.jad.2026.122156_bb0275","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0197-2456(03)00112-0","article-title":"Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design","volume":"25","author":"Rush","year":"2004","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.jad.2026.122156_bb0280","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122156_bb0285","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/JCP.0000000000000183","article-title":"Does mirtazapine interfere with naturalistic diabetes treatment?","volume":"34","author":"Song","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122156_bb0290","unstructured":"Study Quality Assessment Tools | NHLBI, NIH [WWW Document], n.d. URL https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools (accessed 9.3.25)."},{"key":"10.1016\/j.jad.2026.122156_bb0295","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s42255-023-00839-2","article-title":"The serotonin transporter sustains human brown adipose tissue thermogenesis","volume":"5","author":"Suchacki","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.jad.2026.122156_bb0300","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40263-017-0436-x","article-title":"Impact of muscarinic M3 receptor antagonism on the risk of type 2 diabetes in antidepressant-treated patients: a case-controlled study","volume":"31","author":"Tran","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2026.122156_bb0305","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2337\/db11-0870","article-title":"A novel mechanism for regulating hepatic glycogen synthesis involving serotonin and cyclin-dependent Kinase-5","volume":"61","author":"Tudhope","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.jad.2026.122156_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2025.1621887","article-title":"New and emerging pharmacologic treatments for MDD","volume":"16","author":"Uyar","year":"2025","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2026.122156_bb0315","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2353\/ajpath.2010.091198","article-title":"Histamine regulation in glucose and lipid metabolism via histamine receptors: model for nonalcoholic steatohepatitis in mice","volume":"177","author":"Wang","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jad.2026.122156_bb0320","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.4088\/JCP.v67n1204","article-title":"Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine","volume":"67","author":"Weber-Hamann","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122156_bb0325","first-page":"241","article-title":"Functional connectivity between glutamate receptor antagonism and insulin pathways: implications for modeling mechanism of action of ketamine\/esketamine and dextromethorphan in depression treatment","volume":"10","author":"Wong","year":"2025","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.jad.2026.122156_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/ani10081423","article-title":"Mirtazapine reduces adipocyte hypertrophy and increases glucose transporter expression in obese mice","volume":"10","author":"Wu","year":"2020","journal-title":"Animals"},{"key":"10.1016\/j.jad.2026.122156_bb0335","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13643-023-02185-6","article-title":"Efficacy and safety of duloxetine in painful diabetic peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Wu","year":"2023","journal-title":"Syst. Rev."},{"key":"10.1016\/j.jad.2026.122156_bb0340","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70383","article-title":"Serotonin (5-Hydroxytryptamine): metabolism, signaling, biological functions, diseases, and emerging therapeutic opportunities","volume":"6","author":"Zhang","year":"2025","journal-title":"MedComm"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726010086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726010086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:05:25Z","timestamp":1784577925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726010086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":71,"alternative-id":["S0165032726010086"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.122156","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the effects of antidepressants on measures of insulin resistance in major depressive disorder: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.122156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122156"}}